<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05623917</url>
  </required_header>
  <id_info>
    <org_study_id>P.T.REC/012/004115</org_study_id>
    <nct_id>NCT05623917</nct_id>
  </id_info>
  <brief_title>Sleep Quality, Stress, Depression, Blood Pressure Responses to Diaphragmatic Respiratory Exercise in Systemic Sclerosis</brief_title>
  <official_title>Sleep Quality, Stress/Depression, Autonomic Responses to Breathing Exercise in Systemic Sclerosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      systemic sclerosis women usually report problems such as stress/depression, fatigue, not deep&#xD;
      sleep. complementary therapies may improve the reported problems in those patients&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      the assignment of females with systemic sclerosis (n= forty females) to two equal groups. the&#xD;
      group will contain 20 females. the first group will receive tele-supervised Diaphragmatic&#xD;
      Respiratory Exercise ( applied at the homes of the females two times per the day, at the&#xD;
      morning and at the evening, twenty minutes for every time, the sessions will be applied daily&#xD;
      for 3 months in all females). the females in the second group will be waiting-list control&#xD;
      females.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 15, 2022</start_date>
  <completion_date type="Anticipated">March 15, 2023</completion_date>
  <primary_completion_date type="Anticipated">March 15, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>cortisol</measure>
    <time_frame>12 weeks</time_frame>
    <description>a hormone that is usually represents as a stress hormone</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>systolic blood pressure</measure>
    <time_frame>12 weeks</time_frame>
    <description>it will be measured by sphygmomanometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>diastolic blood pressure</measure>
    <time_frame>12 weeks</time_frame>
    <description>it will be measured by sphygmomanometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pulse rate</measure>
    <time_frame>12 weeks</time_frame>
    <description>rate of pulse per minute</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>respiratory rate</measure>
    <time_frame>12 weeks</time_frame>
    <description>rate of respiration per minute</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Health Questionnaire</measure>
    <time_frame>12 weeks</time_frame>
    <description>it contains eight questions. it will used to assess depression</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hamilton Anxiety Rating Scale</measure>
    <time_frame>12 weeks</time_frame>
    <description>a psychological questionnaire used to assess psychological satus</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fatigue using visual analogue scale</measure>
    <time_frame>12 weeks</time_frame>
    <description>it will be measured using visual analogue scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pittsburgh Sleep Quality Index</measure>
    <time_frame>12 weeks</time_frame>
    <description>it will measured the sleeping quality of females</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Systemic Sclerosis</condition>
  <arm_group>
    <arm_group_label>Exercised group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>the group will contain 20 females. the females will receive tele-supervised Diaphragmatic Respiratory Exercise ( applied at the homes of the females two times per the day, at the morning and at the evening, twenty minutes for every time, the sessions will be applied daily for 3 months in all females).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>he females in the this group will be waiting-list control females who will receive no training.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Tele-supervised diaphragmatic respiratory exercise</intervention_name>
    <description>the group will contain 20 females. the females will receive tele-supervised Diaphragmatic Respiratory Exercise ( applied at the homes of the females two times per the day, at the morning and at the evening, twenty minutes for every time, the sessions will be applied daily for 3 months in all females).</description>
    <arm_group_label>Exercised group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  systemic sclerosis women (40 females)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  obesity&#xD;
&#xD;
          -  thoracic diseases&#xD;
&#xD;
          -  heart disease&#xD;
&#xD;
          -  females with mental diseases&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>based on self-representation of gender identity.</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ali Ismail, lecturer</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ali Ismail, lecturer</last_name>
    <phone>02 01005154209</phone>
    <email>ali.mohamed@pt.cu.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>ahmed elfahl, Lecturer</last_name>
    <email>ahmed.elfahl@buc.edu.eg</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cairo Unoversity</name>
      <address>
        <city>Giza</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ali Ismail, lecturer</last_name>
      <phone>01005154209</phone>
      <email>allooka2012@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>November 2022</verification_date>
  <study_first_submitted>November 14, 2022</study_first_submitted>
  <study_first_submitted_qc>November 18, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 21, 2022</study_first_posted>
  <last_update_submitted>November 18, 2022</last_update_submitted>
  <last_update_submitted_qc>November 18, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 21, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Ali Mohamed Ali ismail</investigator_full_name>
    <investigator_title>lecturer of Physical Therapy for Cardiovascular / Respiratory Disorder and Geriatrics, Faculty of Physical Therapy, Cairo University</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Scleroderma, Systemic</mesh_term>
    <mesh_term>Scleroderma, Diffuse</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

